
SBRA Stock Forecast & Price Target
SBRA Analyst Ratings
Bulls say
Sabra Health Care REIT is poised for long-term success due to its diversified portfolio of healthcare real estate properties, strong balance sheet, and attractive investment opportunities. The company's recent portfolio updates, including the transition of 26 Avamere-leased properties to Cascadia Healthcare and a reduction in behavioral health exposure, demonstrate management's commitment to optimizing its assets and improving cash flow. SBRA's focus on acquiring newer senior housing assets at attractive lease yields further supports its potential for internal and external growth.
Bears say
Sabra Health Care REIT is facing challenges in their business model, as seen in their overall decrease in revenue. The concentration of their operations in the United States leaves them vulnerable to changes in healthcare policies and regulations. Despite small agreements and tenant resolutions increasing annual NOI, the overall impact is not enough to counterbalance the negative outlook on the company's fundamentals. Furthermore, the increase in G&A expenses and revised FFO guidance point to potential financial struggles in the future.
This aggregate rating is based on analysts' research of Sabra Health Care and is not a guaranteed prediction by Public.com or investment advice.
SBRA Analyst Forecast & Price Prediction
Start investing in SBRA
Order type
Buy in
Order amount
Est. shares
0 shares